You are here
Australian Regulatory Guidelines for Advertising Therapeutic Goods (ARGATG)
Guidance for advertisers
This guidance for advertisers applies to the current Therapeutic Goods Advertising Code 2015 but incorporates amendments to the Therapeutic Goods Act 1989 (the Act) that came into effect on 6 March 2018, and has been further updated to provide specific information on advertising biologicals and to also include more background information on advertising requirements.
The Therapeutic Goods Advertising Code (No.2) 2018 was made on 31 October 2018 to replace the 2018 Code which will come into effect on 1 January 2019. A summary of the changes is available. To assist advertisers with implementation, we have also published guidance material; Complying with the Therapeutic Goods Advertising Code (No. 2) 2018.
|Version||Description of change||Author||Effective date|
|V1.0||Original publication||Advertising compliance section and Regulatory guidance team||June 2018|
Additional information about:
Some minor editorial changes have also been made
|Advertising compliance section and Regulatory guidance team||July 2018|
|V2.1||Minor editorial changes to reflect the making of the Therapeutic Goods Advertising Code (No.2) 2018 (the Code) and the inclusion of the Pricing Information Code of Practice at Schedule 4 of the Code from 1 January 2019.||Advertising Education and Assurance Section||November 2018|
|V2.2||Updated Advertising vaccination services and vaccines||Advertising Education and Assurance Section||November 2019|
|V2.3||Changes to the information about advertising pre-approvals||Advertising Education and Assurance Section||November 2019|
|V2.4||Updated Cosmetic medicine interface||Advertising Education and Assurance Section||December 2019|